Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report

Authors: Juana Alonso-Titos, Lara Perea-Ortega, Eugenia Sola, Alvaro Torres-Rueda, Myriam León, Remedios Toledo, Ana D. Duarte, Teresa Vazquez, Maria Dolores Martinez-Esteban, Alicia Bailen, Pedro Ruiz-Esteban, Domingo Hernandez

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Morbidity associated with monoclonal gammopathy of renal significance is high due to the severe renal lesions and the associated systemic alterations. Accordingly, early diagnosis is fundamental, as is stopping the clonal production of immunoglobulins using specific chemotherapy.

Case presentation

A 75-year-old man with chronic renal disease of unknown origin since 2010 experienced rapid worsening of renal function over a period of 6 mos. Bone marrow biopsy showed monoclonal gammopathy of undetermined significance. Kidney biopsy showed the presence of C3 glomerulonephritis, with exclusive deposits of C3 visible on immunofluorescence and a membranoproliferative pattern on light microscopy. Skin biopsy showed endothelial deposition of complement. Given both the renal and cutaneous involvement the patient was considered to have monoclonal gammopathy of renal significance. We considered an underlying pathogenic mechanism for the renal alteration secondary to activation of the alternative complement pathway by the anomalous immunoglobulin. Despite treatment with plasmapheresis, bortezomib and steroids, advanced chronic kidney disease developed.

Conclusions

The possible underlying cause of the monoclonal gammopathy of renal significance suggests that monoclonal gammopathy should be considered in adult patients with membranoproliferative glomerulonephritis.
Literature
1.
go back to reference Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand J-P, Picken MM, Herrera GA, Kastritis E, Merlini G, Roussel M, Fervenza FC, Dispenzieri A, Kyle RA, Nasr SH. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87:698–711.CrossRefPubMed Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand J-P, Picken MM, Herrera GA, Kastritis E, Merlini G, Roussel M, Fervenza FC, Dispenzieri A, Kyle RA, Nasr SH. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87:698–711.CrossRefPubMed
2.
go back to reference Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LDSS. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis. 2013;62:506–14.CrossRefPubMedPubMedCentral Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LDSS. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis. 2013;62:506–14.CrossRefPubMedPubMedCentral
3.
go back to reference Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB. Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis. 2003;42:87–95.CrossRefPubMed Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB. Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis. 2003;42:87–95.CrossRefPubMed
4.
go back to reference Yadav P, Leung N, Sanders PW, Cockwell P. The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease. Kidney Int. 2015;87:692–7.CrossRefPubMed Yadav P, Leung N, Sanders PW, Cockwell P. The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease. Kidney Int. 2015;87:692–7.CrossRefPubMed
5.
go back to reference Ramirez GA, De Luca G, Dell’Antonio G, Baldissera E, Suma GV, Tresoldi M, Dagna L. C3-glomerulopathy and MGUS: the skin beyond the kidney. QJM. 2018;111:187–8.CrossRefPubMed Ramirez GA, De Luca G, Dell’Antonio G, Baldissera E, Suma GV, Tresoldi M, Dagna L. C3-glomerulopathy and MGUS: the skin beyond the kidney. QJM. 2018;111:187–8.CrossRefPubMed
6.
go back to reference Chauvet S, Frémeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, François A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Blood. 2017;129:1437–47.CrossRefPubMed Chauvet S, Frémeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, François A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Blood. 2017;129:1437–47.CrossRefPubMed
7.
go back to reference Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol. 2007;139:730–43.CrossRefPubMed Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol. 2007;139:730–43.CrossRefPubMed
8.
go back to reference Andersen CA, Marcussen N, Gregersen JW. Recovery of renal function succeeding stem cell transplant: a case of C3 Glomerulonephiritis secondary to monoclonal gammopathy. Clin Kidney J. 2013;6:639–42.CrossRefPubMedPubMedCentral Andersen CA, Marcussen N, Gregersen JW. Recovery of renal function succeeding stem cell transplant: a case of C3 Glomerulonephiritis secondary to monoclonal gammopathy. Clin Kidney J. 2013;6:639–42.CrossRefPubMedPubMedCentral
9.
go back to reference Sethi S, Zand L, Leung N, Smith RJH, Jevremonic D, Herrmann SS, Fervenza FC. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol. 2010;5:770–82.CrossRefPubMedPubMedCentral Sethi S, Zand L, Leung N, Smith RJH, Jevremonic D, Herrmann SS, Fervenza FC. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol. 2010;5:770–82.CrossRefPubMedPubMedCentral
10.
go back to reference Rabasco C, Cavero T, Román E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernández-Juarez G, González F, Ávila A, Baltar JM, Díaz M, Alegre R, Elías S, Antón M, Frutos MA, Pobes A, Blasco M, Martín F, Bernis C, Macías M, Barroso S, de Lorenzo A, Ariceta G, López-Mendoza M, Rivas B, López-Revuelta K, Campistol JM, Mendizábal S, de Córdoba SR, Praga M. Spanish Group for the Study of glomerular diseases (GLOSEN): effectiveness of mycophenolate mofetil in C3 glomerulonephritis. Kidney Int. 2015;88:1153–60.CrossRefPubMed Rabasco C, Cavero T, Román E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernández-Juarez G, González F, Ávila A, Baltar JM, Díaz M, Alegre R, Elías S, Antón M, Frutos MA, Pobes A, Blasco M, Martín F, Bernis C, Macías M, Barroso S, de Lorenzo A, Ariceta G, López-Mendoza M, Rivas B, López-Revuelta K, Campistol JM, Mendizábal S, de Córdoba SR, Praga M. Spanish Group for the Study of glomerular diseases (GLOSEN): effectiveness of mycophenolate mofetil in C3 glomerulonephritis. Kidney Int. 2015;88:1153–60.CrossRefPubMed
11.
go back to reference Bridoux F, Desport E, Frémeaux-Bacchi V, Chong CF, Gombert J-M, Lacombe C, Quellard N, Touchard G. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol. 2011;6:2165–74.CrossRefPubMedPubMedCentral Bridoux F, Desport E, Frémeaux-Bacchi V, Chong CF, Gombert J-M, Lacombe C, Quellard N, Touchard G. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol. 2011;6:2165–74.CrossRefPubMedPubMedCentral
Metadata
Title
C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report
Authors
Juana Alonso-Titos
Lara Perea-Ortega
Eugenia Sola
Alvaro Torres-Rueda
Myriam León
Remedios Toledo
Ana D. Duarte
Teresa Vazquez
Maria Dolores Martinez-Esteban
Alicia Bailen
Pedro Ruiz-Esteban
Domingo Hernandez
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0927-0

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue